Loading...

Aging US Demand Will Expand Long-Term Care Opportunities

Published
24 Sep 24
Updated
21 Sep 25
AnalystConsensusTarget's Fair Value
US$18.00
9.1% undervalued intrinsic discount
21 Sep
US$16.36
Loading
1Y
48.2%
7D
3.3%

Author's Valuation

US$18

9.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on21 Sep 25
Fair value Increased 5.88%

Despite a slight downgrade in consensus revenue growth forecasts, a higher forward P/E multiple has driven the consensus Analyst Price Target for Healthcare Services Group up from $17.00 to $18.00. What's in the News Repurchased 566,997 shares for $7.6 million in the latest tranche, completing 2,690,108 shares for $30.67 million under the buyback program.

Shared on31 Jul 25

With no material changes in the discount rate or future P/E, the consensus analyst price target for Healthcare Services Group remains steady at $17.00. What's in the News The company is prioritizing capital allocation towards organic growth, acquisitions, and opportunistic share repurchases, with an active evaluation of acquisition opportunities and $14.6 million in YTD buybacks; no acquisitions completed this quarter.

Shared on01 May 25
Fair value Increased 20%

Shared on23 Apr 25
Fair value Increased 3.14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25
Fair value Decreased 8.73%

AnalystConsensusTarget has decreased revenue growth from 5.0% to 4.0%, decreased profit margin from 4.4% to 3.7%, increased future PE multiple from 14.6x to 16.5x and increased shares outstanding growth rate from -0.0% to 0.0%.

Shared on09 Apr 25
Fair value Increased 8.77%

Shared on02 Apr 25
Fair value Increased 1.40%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Decreased 0.80%

AnalystConsensusTarget has increased revenue growth from 3.5% to 4.0%.